Pages that link to "Q35904219"

The following pages link to Randomized phase II/III clinical trial of elpamotide for patients with advanced pancreatic cancer: PEGASUS-PC Study (Q35904219):

Displaying 22 items.

• Gemcitabine mono-therapy versus gemcitabine plus targeted therapy in advanced pancreatic cancer: a meta-analysis of randomized phase III trials (Q30235450) (← links)
• Phase II clinical trial of peptide cocktail therapy for patients with advanced pancreatic cancer: VENUS-PC study. (Q37611667) (← links)
• Angiogenesis in pancreatic ductal adenocarcinoma: A controversial issue (Q37629083) (← links)
• From Clinical Standards to Translating Next-Generation Sequencing Research into Patient Care Improvement for Hepatobiliary and Pancreatic Cancers (Q37631655) (← links)
• Interim analysis of a phase I/IIa trial assessing E39 GM-CSF, a folate binding protein vaccine, to prevent recurrence in ovarian and endometrial cancer patients (Q37716642) (← links)
• Overview of pre-clinical and clinical studies targeting angiogenesis in pancreatic ductal adenocarcinoma. (Q38684978) (← links)
• Current status and future prospects of peptide-based cancer vaccines (Q38780728) (← links)
• From amino acid sequence to bioactivity: The biomedical potential of antitumor peptides. (Q38787128) (← links)
• Targeted therapies for the treatment of non-small-cell lung cancer: Monoclonal antibodies and biological inhibitors (Q39004424) (← links)
• Phase II clinical trial using novel peptide cocktail vaccine as a postoperative adjuvant treatment for surgically resected pancreatic cancer patients (Q39175584) (← links)
• A phase 1 trial extension to assess immunologic efficacy and safety of prime-boost vaccination with VXM01, an oral T cell vaccine against VEGFR2, in patients with advanced pancreatic cancer. (Q52597561) (← links)
• Chemotherapy and radiotherapy for advanced pancreatic cancer. (Q52647259) (← links)
• Consensus statement on mandatory measurements in pancreatic cancer trials (COMM-PACT) for systemic treatment of unresectable disease. (Q52672325) (← links)
• Immunotherapy in pancreatic adenocarcinoma-overcoming barriers to response. (Q55073226) (← links)
• Trial watch: peptide-based vaccines in anticancer therapy (Q57082680) (← links)
• First-line chemotherapy regimens for locally advanced and metastatic pancreatic adenocarcinoma: a Bayesian analysis (Q59790992) (← links)
• Angiogenesis in Pancreatic Cancer: Pre-Clinical and Clinical Studies (Q64079046) (← links)
• Efficacy and safety of gemcitabine plus anti-angiogenesis therapy for advanced pancreatic cancer: a systematic review and meta-analysis of clinical randomized phase III trials (Q64237939) (← links)
• Pancreatic cancer (Q87198210) (← links)
• Therapies Targeting the Tumor Stroma and the VEGF/VEGFR Axis in Pancreatic Ductal Adenocarcinoma: a Systematic Review and Meta-Analysis (Q90655994) (← links)
• Recent advances in chemotherapy for pancreatic cancer: evidence from Japan and recommendations in guidelines (Q93041688) (← links)
• TAS0314, a novel multi-epitope long peptide vaccine, showed synergistic antitumor immunity with PD-1/PD-L1 blockade in HLA-A*2402 mice (Q100559219) (← links)